Aguilera JT

Idioma: Español
Referencias bibliográficas: 22
Paginas: 209-213
Archivo PDF: 173.82 Kb.

RESUMEN

La neumonía se define como una inflamación y consolidación de tejido pulmonar debido a un agente infeccioso, aquella que se produce fuera de un hospital se considera neumonía adquirida en la comunidad. El tratamiento antibiótico apropiado reduce la duración de los síntomas y complicaciones, pero debido a que el agente específico causal se desconoce en la mayoría de casos, se debe iniciar tratamiento antibiótico empírico temprano en el curso de esta enfermedad.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Alfageme I, Aspa J, Bello S, Blanquer J, Blanquer R, Borderías L, et al. Normativas para el diagnóstico y tratamiento de la neumonía adquirida en la comunidad. Sociedad Española de Neumología y cirugía Torácica. Arch Bronconeumol 2005;41:272-89.

2. Arancibia F, Bauer TT, Ewig S, et al. Community-acquired pneumonia due to Gram-negative bacteria and Pseudomonas aeruginosa: incidence, risk and prognosis. Arch Intern Med 2002;162: 1849-1858.

3. Baudouin S, Lim W, Hill A, Jamieson C, Jeune L, Macfarlane J, et al. Guidelines for the management of community-acquired pneumonia in adults: update 2009. Thorax an international journal of respiratory medicine Vol 64;III pp 28-39.

4. Calvo-Sánchez AJ, Girón- González JA, López-Prieto D, et al. Multivariate analysis of risk factors for infectious due to penicillinresistant and multidrug-resistant Streptococcus pneumoniae: a multicenter study. Clin Infect Dis 1997;24:1052-1059.

5. Fang GD, FineM, Orloff J, et al. New and emerging etiologies for community-acquired pneumonia with implications for theraphy: a prospective multicenter study of 359 cases. Medicine 1990;69:307-316.

6. Farr BM, Sloman AJ, Fish MJ. Predicting death in pacients hospitalized for communityAGUILERA: MANEJO DE NEUMONIA ADQU IRIDA EN COMUNIDAD 213 acquired pneumonia. Ann Intern Med 1991;115:428-436.

7. Find MD, Smith MA, Carson CA, et al. Prognosis and outcomes of pacients with community acquired pneumonia: a meta-analysis. JAMA 1996;275:134-141.

8. Find MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk pacients with communityacquired pneumonia. N Engl J Med 1997;336:243-250.

9. Fishman A, Elias J, Fishman J, Grippi M, Senior R, Pack A. (2008). Acute Bronchitis and Community-Aquired Pneumonia. En Thomas J. Marrie, Fishman´s pulmonary diseases and disorders (4th Ed pp 2098-2111).

10. Houck PM, Bratzler DW, Nsa W, et al. Timing of antibiotic administration and outcomes for medicare pacients hospitalized with community-acquired pneumonia. Arch Intern Med 2004;164:637-644.

11. Lim WS, van der Earden MM, Laing R, at al: Defining communityacquired pneumonia severity on presentation to hospital: An international derivation and validation study. Thorax 58:377- 382,2003.

12. Mandell LA, Marrie TJ, Grossman RF, et al. , and the Canadian CAP Working Group. Canadian Guidelinesfor the initial management of community-acquired pneumonia: an evidence based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. Clin Infect Dis 2000;31:383-421.

13. Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/ American thoracis Society consensus guidelines on the management of communityacquired pneumonia in adults. Clin Infect Dis 2007;44:S27-S72.

14. McFadden JR, Price RC, Eastwood HD, at al. Raised respiratory rate in elderly pacients: a valuable physical sign. Br Med J 1982;284:626-627.

15. Niederman MS,Mandell LA, Anzueto A, et al. Guidelines for the management of adults with community-acquired lower respiratory tract infections: Diagnosis, assessment of severity, antimicrobial therapy and prevention. Am J respire Crit Care Med 2001;163:1730-1754.

16. Niederman MS, McCombs JI, Unger AN, et al. The Cost of treating community-acquired pneumoniae. Clin Ther 1998; 20:820-837.

17. Ramos A. Factores pronósticos de la neumonía por aspiración adquirida en la comunidad. Med Clin Bar 2002;119(3):81-84.

18. Rhew DC, Tu GS, Ofman J, at al. Early swith and early discharge strategies in pacients with community-acquired pneumonia: a meta-analysis. Arch Intern Med 2001;161:722-727.

19. Ruiz-Gonzalez A, Falguera M,Nogues A, et al. Is Streptococcus pneumoniae the leading cause of pneumonia of unknown atiology? A microbiologic study of lung aspirates in consecutive pacients with community-acquired pneumonia. Am J Med 1999;106:385-390.

20. Starczewski AR, Allen SC, Vargas E, et al. Clinical prognostic indices of fatality in elderly pacients admitted to hospital with acute pneumonia. Age Aging 1988;17:181-186.

21. Syrjala H, Broas M, SuramoI, et al. High-resolution computed tomography for the diagnosis of community-acquired pneumonia. Clin Infect Dis 1998;27:358-363.

22. Waterer GW, Somes GW, Wonderink RG. Monotheraphy may be suboptimal for severe bacteremic pneumococcal pneumonia. Arch Intern Med 2001;161:1837-1842.